2024 Prediction from Laura Kline, MBA, CPCU
Laura Kline, MBA, CPCU is the Senior Vice President of Business Development at The Doctors Company. She predicts "APCs will be critical to access care."
We asked our readers and some members of our editorial advisory board to make predictions for 2024. Here's what Laura Kline, MBA, CPCU had to say:
“Through 2030, Conning strategic studies show that the number of physicians is projected to grow at a compound annual growth rate (CAGR) of less than 1%, while the CAGR for nurse practitioners and physician assistants is forecast at 6.8% and 4.3%, respectively. Advanced practice clinicians (APCs) are among the fasting growing of all professions and their numbers are expected to double over this decade. In a time of present and predicted physician shortages, an approach of thoughtfully structuring care teams to build in roles for APCs will be critical to expanding access to care, containing costs, relieving burdens for beleaguered physicians and continuing to provide high-quality and attentive care.”
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More
